Table 3.

Reclassification of follicular lymphoma patients from FLIPI to BioFLIPI risk model

 
 

CD4+ intrafollicular; CD4− intrafollicular.

View Large
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal